Session Objective:

1) Understand the differential diagnosis of “Red Eye”;

2) Understand the potential causes and treatment options for vision decline and sudden vision loss;

3) Identify eye conditions that will need referral to Ophthalmology

 

Session Faculty: 

Manju Subramanian MD, FACS plans on discussing unlabeled/investigational uses of a commercial product Bevacizumab 

 

Session date: 
08/02/2022 - 12:00pm to 1:00pm EDT
Location: 
Zoom
United States
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation
Please login or register to take this course.